Skip to main content

Archana Shanker considers the implications of the grant of a compulsory licence for the very first time in the Indian patent system.

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

The Controller General of Patents has set a benchmark in this landmark decision by invoking Section 84(1), a crucial provision of the Indian Patents Act which allows any person interested to file an application for grant of compulsory licence on a patent at any time from three years after grant on various grounds mentioned in the Indian Patents Act.

This article was published in Life Sciences Intellectual Property Review 2012.

To continue reading, please contact us at email@anandandanand.com

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Nov 21, 2026

Patent applications, trademark registrations, design records and intellectual property judgments form an important part of India’s public IP infrastructure.

Who Owns India’s IP Data? Commercial Scraping and Copyright Protection
News & Updates, Thought Leadership
•
Nov 18, 2026

A few seconds of weather footage broadcast in New Delhi ended up at the center of a federal copyright lawsuit in California. A news broadcaster based in

Can Foreign Copyright Owners Sue Indian Broadcasters Abroad? The Territorial Reach of Copyright Disputes
News & Updates, Thought Leadership
•
Nov 14, 2026

Generative artificial intelligence systems are trained on large volumes of information, including text, images, news articles and other digital material.

Can AI Training be Copyright Infringement? The ANI v. OpenAI Dispute in India
News & Updates, Thought Leadership
•
Nov 11, 2026

Think about the apps you use every day. Their visual identity is often the first thing you recognise: the arrangement of icons, navigation menus, buttons,

Can You Patent the Look of an App? GUI and Icon Protection in India